About CCBR Vejle
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kowa Research Europe
8
Pfizer
5
Nordic Bioscience A/S
3
Biogen
2
Coloplast A/S
2
Genentech, Inc.
1
Menarini Group
1
Regeneron Pharmaceuticals
1
Statens Serum Institut
1
Unigene Laboratories Inc.
1
Clinical Trials at CCBR Vejle
During the past decade, CCBR Vejle conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 8 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
2005-09-01
2006-05-01
Completed
962
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
355
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
2005-12-01
2007-06-01
Completed
418
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-06-01
2007-12-01
Completed
545
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
2006-06-01
2007-08-01
Completed
178
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
2006-08-01
2008-04-01
Completed
214
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CCBR Vejle" #1 sponsor was "Kowa Research Europe" with 8 trials, followed by "Pfizer" with 5 trials
sponsored, "Nordic Bioscience A/S" with 3 trials sponsored, "Biogen" with 2 trials sponsored and "Coloplast A/S"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR Vejle"
#1 collaborator was "Novartis" with 3 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "CCBR Clinical Research" with 1 trials as a collaborator and "Larix A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at CCBR Vejle
According to Clinical.Site data, the most researched conditions in "CCBR Vejle" are
"Dyslipidemia" (6 trials), "Hypercholesterolemia" (4 trials), "Alzheimer's Disease" (3 trials), "Osteoarthritis" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "CCBR Vejle" in a lesser frequency.
Clinical Trials Intervention Types at CCBR Vejle
Most popular intervention types in "CCBR Vejle" are "Drug" (22 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Pitavastatin" (6 trials), "Atorvastatin" (3 trials), "Nicotine Replacement Therapy Patch" (2 trials) and "SMC021 Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CCBR Vejle
The vast majority of trials in "CCBR Vejle" are
23 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at CCBR Vejle
Currently, there are NaN active trials in "CCBR Vejle".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in CCBR Vejle,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in CCBR Vejle, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".